Publication Information

{'id': 'https://openalex.org/W2365248866', 'doi': None, 'title': "Pathological Changes in Specific Brain Regions of Mice with Parkinson's Disease and Effect of Poly(ADP-ribose) Polymerase Inhibitor", 'display_name': "Pathological Changes in Specific Brain Regions of Mice with Parkinson's Disease and Effect of Poly(ADP-ribose) Polymerase Inhibitor", 'publication_year': 2006, 'publication_date': '2006-01-01', 'ids': {'openalex': 'https://openalex.org/W2365248866', 'mag': '2365248866'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://en.cnki.com.cn/Article_en/CJFDTOTAL-JPKX200604005.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764639538', 'display_name': 'Jiepou kexue jinzhan', 'issn_l': '1006-2947', 'issn': ['1006-2947'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320584', 'host_organization_name': 'CRC Press', 'host_organization_lineage': ['https://openalex.org/P4310320547', 'https://openalex.org/P4310320584'], 'host_organization_lineage_names': ['Taylor & Francis', 'CRC Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5055219102', 'display_name': 'Chaodong Zhang', 'orcid': 'https://orcid.org/0000-0002-3757-4310'}, 'institutions': [{'id': 'https://openalex.org/I91656880', 'display_name': 'China Medical University', 'ror': 'https://ror.org/032d4f246', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I91656880']}, {'id': 'https://openalex.org/I4210140515', 'display_name': 'First Hospital of China Medical University', 'ror': 'https://ror.org/04wjghj95', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210140515']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Zhang Chao-dong', 'raw_affiliation_strings': ['Department of Neurology,the First Clinical Hospital,China Medical University,Liaoning Shenyang 110001 China)'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology,the First Clinical Hospital,China Medical University,Liaoning Shenyang 110001 China)', 'institution_ids': ['https://openalex.org/I91656880', 'https://openalex.org/I4210140515']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5055219102'], 'corresponding_institution_ids': ['https://openalex.org/I91656880', 'https://openalex.org/I4210140515'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9915, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9915, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10085', 'display_name': "Parkinson's Disease Mechanisms and Treatments", 'score': 0.9709, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2780938664', 'wikidata': 'https://www.wikidata.org/wiki/Q753278', 'display_name': 'Substantia nigra', 'level': 4, 'score': 0.9360372}, {'id': 'https://openalex.org/C2780062018', 'wikidata': 'https://www.wikidata.org/wiki/Q1319792', 'display_name': 'Striatum', 'level': 3, 'score': 0.7714281}, {'id': 'https://openalex.org/C159167319', 'wikidata': 'https://www.wikidata.org/wiki/Q420766', 'display_name': 'Tyrosine hydroxylase', 'level': 3, 'score': 0.62972164}, {'id': 'https://openalex.org/C137183658', 'wikidata': 'https://www.wikidata.org/wiki/Q461076', 'display_name': 'Dopaminergic', 'level': 3, 'score': 0.62089664}, {'id': 'https://openalex.org/C513476851', 'wikidata': 'https://www.wikidata.org/wiki/Q170304', 'display_name': 'Dopamine', 'level': 2, 'score': 0.5675837}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.46147916}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.43705046}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.4166462}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.29288578}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.24580315}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://en.cnki.com.cn/Article_en/CJFDTOTAL-JPKX200604005.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764639538', 'display_name': 'Jiepou kexue jinzhan', 'issn_l': '1006-2947', 'issn': ['1006-2947'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320584', 'host_organization_name': 'CRC Press', 'host_organization_lineage': ['https://openalex.org/P4310320547', 'https://openalex.org/P4310320584'], 'host_organization_lineage_names': ['Taylor & Francis', 'CRC Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.54}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2380179380', 'https://openalex.org/W2375803526', 'https://openalex.org/W2375768659', 'https://openalex.org/W2375199869', 'https://openalex.org/W2373139042', 'https://openalex.org/W2371471108', 'https://openalex.org/W2369008311', 'https://openalex.org/W2368139399', 'https://openalex.org/W2362888834', 'https://openalex.org/W2361199689', 'https://openalex.org/W2354292106', 'https://openalex.org/W2071660479', 'https://openalex.org/W2032134772', 'https://openalex.org/W2028580402', 'https://openalex.org/W2027648752', 'https://openalex.org/W2023713693', 'https://openalex.org/W2008168871', 'https://openalex.org/W1997281924', 'https://openalex.org/W1996256790', 'https://openalex.org/W161268098'], 'abstract_inverted_index': {'Objective': [0], 'To': [1], 'investigate': [2], 'the': [3, 22, 30, 78, 106, 130, 136, 144], 'change': [4, 62, 153], 'of': [5, 9, 17, 24, 40, 84, 100, 112, 118, 122, 154], 'number': [6, 83, 121], 'and': [7, 15, 21, 57, 73, 81, 86, 105, 125, 133, 135], 'ultrastructure': [8], 'dopaminergic(DA)': [10], 'neurons': [11, 48, 102, 168], 'in': [12, 77, 90, 115, 129, 143, 161], 'substantia': [13, 79, 116, 131], 'nigra': [14, 80, 117, 132], 'striatum': [16, 91], "Parkinson's": [18], 'disease(PD)': [19], 'mice': [20, 33, 42], 'effect': [23], 'poly(ADP-ribose)': [25], 'polymerase(PARP)': [26], 'inhibitor': [27, 164], 'PJ34': [28, 145], 'on': [29], 'neurons.Methods': [31], 'PD': [32, 119, 150, 162], 'model': [34], 'was': [35, 63], 'induced': [36], 'by': [37, 51, 65], 'abdominal': [38], 'injection': [39], '1-methyl-4-phenylv1,2,3,6-tetrahydropyridine(MPTP),some': [41], 'were': [43, 49, 92, 127, 140], 'pretreated': [44, 146], 'with': [45, 95, 110, 149], 'PJ34.The': [46], 'dopamine': [47, 167], 'stained': [50], 'tyrosine': [52], 'hydroxylase(TH)': [53], 'immunohistochemistry': [54], 'at': [55], '2h,24h': [56], '72h': [58], 'time': [59], 'point,the': [60], 'ultrastructural': [61, 137], 'evaluated': [64], 'transmission': [66], 'electron': [67], 'microscope.Results': [68], 'TH': [69, 87], 'immunopositive': [70], 'cell': [71, 123], 'bodies': [72, 124], 'fibers': [74, 126], 'reduced': [75], 'gradually': [76], 'striatum,the': [82], 'synapses': [85], 'positive': [88], 'tibers': [89], 'decreased': [93], 'compared': [94, 148], 'normal': [96], 'control.The': [97], 'nucleus': [98], 'membrane': [99], 'dopaminergic': [101], 'appeared': [103], 'shrinking': [104], 'chromatin': [107], 'showed': [108], 'agglutination': [109, 114], 'tendency': [111], 'border': [113], 'mice.The': [120], 'increased': [128], 'striatum(P0.01)': [134], 'morphological': [138], 'changes': [139], 'alleviated': [141], 'markly': [142], 'group': [147], 'mice.Conclusion': [151], 'The': [152], 'PARP': [155], 'activity': [156], 'takes': [157], 'an': [158], 'important': [159], 'role': [160], 'pathogenesis,PARP': [163], 'can': [165], 'protect': [166], 'from': [169], 'injury.': [170]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2365248866', 'counts_by_year': [], 'updated_date': '2024-12-15T14:48:56.874099', 'created_date': '2016-06-24'}